NEW YORK, August 14, 2026, 17:04 EDT — With U.S. cash markets closed and after-hours trading ongoing, UiPath Inc. NYSE:PATH settled at $16.01 on Friday, a 4.0% decline for the day but still marking a 6.4% gain across the week.
The rally has surpassed Wall Street’s consensus projections. UiPath ended trading 18.2% higher than the average analyst price target of $13.55. The stock also settled 6.7% over the highest analyst estimate, putting all existing forecasts below the current market value.
A new insider transaction offers an updated valuation signal. Chief Accounting Officer Hitesh Ramani disposed of 50,000 shares between Thursday and Friday, totaling $831,250. The average sale price was $16.625, representing a 3.8% premium to Friday’s closing price.
The filing stated the transaction did not occur as an open-market move during the rally. Instead, it was carried out under a Rule 10b5-1 plan that was set up on March 25. These plans provide prearranged trading instructions.
| Weekly price path | Close | Daily move |
|---|---|---|
| Aug. 7 | $15.05 | up 7.5% |
| Aug. 12 | $15.26 | down 2.9% |
| Aug. 13 | $16.68 | rises 9.3% |
| Aug. 14 | $16.01 | slips 4.0% |
| Weekly change | — | advances 6.4% |
Friday saw a decline with volume at 50.6 million shares, falling short of the 79.7 million average as listed by Google Finance. Shares fluctuated between $15.84 and $16.82. The stock is still 19.3% under its 52-week peak of $19.84.
Analysts have yet to increase their price targets. On Thursday, RBC Capital’s Matthew Hedberg reaffirmed a Hold rating and kept his price target at $15. The stock finished that session at $16.68, which is 11.2% higher than his target.
| Analyst recommendations | Count or target | Versus $16.01 close |
|---|---|---|
| Buy | 2 | — |
| Hold | 12 | — |
| Sell | 1 | — |
| Average price target | $13.55 | -15.4% |
| Highest price target | $15.00 | -6.3% |
| Lowest price target | $12.00 | -25.0% |
The insider transaction had little impact compared to UiPath’s overall market value. Ramani disposed of 17.5% of his direct holdings before the trade, leaving him with 235,052 shares. As of Friday’s closing price, those retained shares were valued at roughly $3.76 million.
| Officer’s planned sales | Shares | Price | Proceeds |
|---|---|---|---|
| Aug. 13 | 25,000 | $16.50 | $412,500 |
| Aug. 14 | 25,000 | $16.75 | $418,750 |
| Total | 50,000 | average $16.625 | $831,250 |
| Shares held | 235,052 | — | $3.76m at close |
UiPath’s operational performance is a factor in the rerating. Revenue for the fiscal first quarter climbed 17% to $418.4 million. Annual recurring revenue (ARR) was up 12% at $1.901 billion, with GAAP operating income at $28 million.
Founder and CEO Daniel Dines stated that agentic products were “moving from pilot to production.” UiPath also posted adjusted free cash flow of $130 million and reported $1.42 billion in cash and marketable securities. UiPath fiscal first-quarter release
| Operating measure | Q1 actual | Q2 guidance | Fiscal 2027 guidance |
|---|---|---|---|
| Revenue | $418.4m | $395m–$400m | $1.776bn–$1.781bn |
| ARR | $1.901bn | $1.929bn–$1.934bn | $2.058bn–$2.063bn |
| Non-GAAP operating income | $92m | Approximately $75m | Approximately $430m |
| GAAP operating income | $28m | No guidance | No guidance |
With a market capitalization of $8.30 billion as of Friday, UiPath is currently trading at roughly 4.7 times the midpoint of its projected fiscal 2027 revenue. The company’s trailing price-to-earnings ratio stands at approximately 26.4. Investors are valuing the stock based on expectations of ongoing double-digit growth in recurring revenue.
The outlook requires follow-through. UiPath projects second-quarter revenue to fall short of the first-quarter figure, despite growth in ARR. To support a share price above all existing analyst targets, investors will need to see higher recurring revenue and improved operating leverage.
Risks: A slower pace of enterprise AI rollouts might dampen ARR growth, potentially causing shares to retreat toward the $13.55 consensus. Additional insider sales as scheduled could also weigh on sentiment. Conversely, a robust quarter or upward revisions to targets could support the recent rerating.
The initial valuation level to watch next week is $15, since it aligns with the highest target released so far. If shares finish below this point, nearly all of Thursday’s gains would be lost. Staying above $16 would preserve the gap set by analysts.
Related articles: NYSE:PATH
